TOMMIE CASSIDY: Open Payments
NPI 1982861621 · SPRINGHILL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 8 payments from 7 companies in 2025. Trend: 2023 $159 · 2024 $151 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $43 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: Assure WCD, VRAYLAR, Kerendia, KEVEYIS, QULIPTA, MOUNJARO, JARDIANCE, ELIQUIS.
Industry payments across LA — which companies pay providers there.
